Do you recall the blog we wrote about biochemist Jennifer Doudna, who won a Nobel prize for her work on CRISPR gene editing? Recently, she has partnered with the science development company Danaher to conduct research on rare diseases. They are combining precise technology from Danaher's factory with Doudna's experience from her Innovative Genomics Institute to demonstrate the potential of CRISPR cure in other therapies. Their primary focus is on hemophagocytic lymphohistiocytosis and Artemis-SCID, two life-threatening rare diseases that affect immunity. If the therapies are successful, it could push the limits of gene editing and bring new hope to those affected by rare diseases.
link to the article: https://www.fiercebiotech.com/biotech/crispr-pioneer-doudna-allies-danaher-gene-editing-center-rare-disease-and-beyond
and to the Jennifer Doudna blog: https://www.young4stem.com/post/dr-doudna